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Despite major advances in T cell receptor (TCR) biology and structure, how peptide–MHC
complex (pMHC) ligands trigger αβ TCR activation remains unresolved. Two views exist.
One model postulates that monomeric TCR–pMHC ligation events are sufﬁcient while a
second proposes that TCR–TCR dimerization in cis via Cα domain interaction plus pMHC
binding is critical. We scrutinized 22 known TCR/pMHC complex crystal structures, and
did not ﬁnd any predicted molecular Cα–Cα contacts in these crystals that would allow for
physiological TCR dimerization. Moreover, the presence of conserved glycan adducts on
the outer face of the Cα domain preclude the hypothesizedTCR dimerization through the Cα
domain. Observed functional consequences of Cα mutations are likely indirect, with TCR
microclusters at the immunological synapse driven by TCR transmembrane/cytoplasmic
interactions via signaling molecules, scaffold proteins, and/or cytoskeletal elements.
Keywords:TCR, receptor dimerization, signal transduction, structural immunology
BACKGROUND
αβ T lymphocytes are components of the adaptive immune sys-
tem that allow vertebrates to distinguish abnormal or foreign cells
from normal cells. This “self” versus “non-self” discrimination is
endowed by surface-bound αβ T cell receptors (TCRs) that are
selected in the thymus (reviewed in Rudolph et al., 2006; Smith-
Garvin et al., 2009; Kim et al., 2012; Kuhns and Davis, 2012; Wang
and Reinherz, 2012). In vertebrates, there are millions to billions
of αβ T cells, each with a slightly different TCR structure on their
surface that confers a unique antigen-binding speciﬁcity. TCRs
recognize antigens bound to MHC molecules on the surface of
other cells. MHC molecules display an array of antigen peptides,
providing a snapshot of the cell’s internal composition. Aberrant
cellular processes, such as viral infection or oncogenic transfor-
mation, are reﬂected by alterations in antigen display. When a T
cell senses a variant peptide (one derived from a viral protein, for
example), cellular signaling pathways are initiated that cause the
T cell to proliferate, differentiate, and mediate effector and regu-
latory functions. T cells are able to detect a variant peptide even if
just a few copies are present among the hundreds of thousands of
normal self-peptides that are displayed by the cell-surface MHC
molecules.
The remarkable speciﬁcity and sensitivity at the heart of protec-
tive T cell immunity has provided the impetus for detailed cellular,
biochemical, molecular, and structural studies of the TCR. The αβ
TCR is a multimeric transmembrane (TM) complex composed
of an Fab-like disulﬁde-linked antigen binding clonotypic het-
erodimer in non-covalent association with the signal transducing
CD3 subunits (CD3εγ, CD3εδ, and CD3ζζ; dimer stoichiome-
try 1:1:1:1; Rudolph et al., 2006; Smith-Garvin et al., 2009; Kim
et al., 2012; Kuhns and Davis, 2012; Wang and Reinherz, 2012).
The α and β subunit ectodomains are composed of membrane
distal Vα and Vβ variable domains linked to membrane proximal
Cα and Cβ constant domains, respectively. These two constant
domains are tethered to their individual TMsegments via connect-
ing peptides. Each CD3ε,γ, and δ subunit contains an extracellular
immunoglobulin (Ig)-like domain, a membrane-proximal stalk
region, a TM segment and a cytoplasmic tail. The interaction
between an αβTCR heterodimer on the T cell and a peptide–MHC
complex (pMHC) ligand on an antigen-presenting cell (APC) ini-
tiates a cascade of downstream signaling events. These events
are transmitted via the immunoreceptor tyrosine-based activation
motif (ITAM) elements in the cytoplasmic tails of the associated
CD3 subunits, whose lengths are substantial relative to those of
the TCR α and β tails and couple with critical tyrosine kinase
pathways involving lck and Zap70 (Reth, 1989; Letourneur and
Klausner, 1992; Acuto et al., 2008; Au-Yueng et al., 2009; van der
Merwe and Dushek, 2011).
ELUCIDATION OF TM RECEPTOR SIGNALING IN OTHER
SYSTEMS: POTENTIAL RELEVANCE FOR THE TCR
MECHANISM
Transmembrane signaling is one of the most intriguing and fun-
damental topics in cell biology. The receptor component of a TM
protein functions to receive an environmental message whereas
the TM and cytoplasmic segments of the protein transduce the
signal into the cell and onward to the nucleus, activating relevant
genes and permitting adaptation to environmental changes. There
has been tremendous progress in how receptors recognize ligands
at the cell surface and the elucidation of the various signaling
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cascades transmitting information inside the cell. For the growth
hormone receptor (GHR), a member of the cytokine receptor
superfamily, binding of the growth hormone ligand causes two
GHRs to dimerize at the cell surface (Cunningham et al., 1991; De
Vos et al., 1992). In so doing, these GHRs bring their two cytoplas-
mic tails in proximity to mediate cross-phosphorylation inside the
cell, resulting in activation. In the case of members of the tyrosine
kinase receptor family such as epithelial growth factor receptor
(EGFR), two EGF ligands bind to two EGFRs (Schlessinger, 2002).
Receptor oligomerization appears to be one general mechanism
for mediating signal transduction. Of note, the juxtaposition of
receptors in an oligomer must be precise, as not any dimer will suf-
ﬁce to initiate signaling (Ballinger and Wells, 1998). On the other
hand, analysis of G protein-coupled receptors (GPCR) show how
allosteric changes in the TM segments of one receptor modulate
TM signaling without a requirement for receptor oligomerization
(Rasmussen et al., 2011).
Despite a wealth of structural and functional data involving
interactions between the TCR and antigenic peptides presented
by MHC molecules on the cell surface as well as signaling events
within the cell, it is still largely unclear how the engagement of
the TCR by pMHC leads to subsequent activation of the intra-
cellular machinery. Given the important role of oligomerization
in cytokine and tyrosine kinase receptor superfamilies, the pos-
sibility of TCR oligomerization as a signaling modality has been
considered early on in the ﬁeld of T cell biology. In this regard,
anticlonotypic TCR αβ mAbs or anti-CD3ε mAb, linked to solid
supports were found to be stimulatory for T cells, replacing the
requirement for both peptide and MHC on APCs in the activation
process (Meuer et al., 1983, 1984). In contrast, soluble anti-
body or Fab fragments of those antibodies were non-activating.
Likewise, more recently, TCR signal transduction initiation was
found to require engagements of multiple pMHC ligands; pMHC
monomer were non-stimulatory and pMHC oligomers were efﬁ-
cient activators (Boniface et al., 1998; Krogsgaard et al., 2005).
These studies were interpreted as showing that ligand-driven
formation of TCR clusters is required for effective activation,
accounting for T cell speciﬁcity and sensitivity.
Along these lines, ligand-speciﬁc oligomerization of αβ TCR
heterodimeric ectodomains was demonstrated in solution using
light scattering methodology (Reich et al., 1997). It was reported
that in the presence of speciﬁc agonist pMHC, that TCR/pMHC
complexes underwent oligomerization. Surface plasma resonance
studies followed, revealing biphasic binding kinetics at 37◦C,
interpreted via a model of TCR dimerization (Alam et al., 1999).
However, another study using these same methods, as well as sed-
imentation equilibrium analytic ultracentrifugation, in addition,
failed to replicate those ﬁndings either with class I or class II MHC
restricted TCRs and their physiologic pMHC ligands (Baker and
Wiley, 2001). In view of these inconsistencies, the role played by
TCR oligomerization was studied further in the membrane con-
text with fully assembled TCRs. Only recently have alternative
force-transduction mechanisms been offered to explain the appar-
ent inability of univalent ligands to trigger T cell responses (vide
infra; Kim et al., 2012). Moreover, due to the paucity of structural
information on TCR TM segments, any potential conformational
changes therein upon ligand binding are unrecognized at present.
MODELS OF TCR ECTODOMAIN TOPOLOGY
Two models of TCR ectodomain topology on the T cell mem-
brane are currently under consideration (Fernandes et al., 2012;
Kim et al., 2012; Kuhns and Davis, 2012). Potential for αβ het-
erodimeric oligomerization differs in these two views. In both
models, the αβ heterodimer is centrally positioned. Figure 1 shows
that in model 1 (top panel), CD3εδ and CD3εγ laterally ﬂank
α and β subunits, respectively. The rationale for this topology
has been detailed extensively in the past and will not be reviewed
here (Kim et al., 2012). In model 2 (bottom panel), the CD3 het-
erodimers localize to one face of the αβ heterodimer and CD3
εδ is rotated ∼270◦ clockwise and CD3εγ rotated ∼90◦ coun-
terclockwise relative to model 1. This orientation juxtaposes the
two non-glycosylated CD3 ectodomains and, thereby, allows the
other side of TCR αβ to be available for homotypic dimeriza-
tion. This “functional sidedness” was inferred by utilization of
FIGURE 1 | αβTCR complex subunit ectodomain topology.Two models
of the topology are shown in the top and bottom panels, termed models 1
and 2, respectively. These are viewed from above theT cell looking down.
Color coding for the CD3 components are green, yellow and mint for CD3γ,
CD3δ, and CD3ε, respectively. TCRα is in red andTCRβ is in blue. The CD3ζζ
homodimer is omitted since it lacks an ectodomain structure. In model 2,
the two-headed arrow is meant to indicate that Cα–Cα interaction dimerizes
twoTCR complexes (Kuhns et al., 2010). See the text for details.
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a dimerization reporter system and BaF3 pro-B cell transfection
studies based on erythropoietin receptor (EPOR) signaling mea-
suring BaF3 cell proliferation and CD3–EPOR fusion constructs
(Kuhns et al., 2010; Kuhns and Davis, 2012). Similarly, a TCR α–
EPOR chimera in conjunction with TCR β TM (TM derived from
EPOR) was interpreted as offering functional evidence for Cα–
Cα dimers (Figure 1, model 2). By mutation analysis in BaF3
cells, the dimer interface was mapped to the C and F strands
of the Cα domain. In this view, the dimer juxtaposes two TCR
complexes to facilitate signaling through the cellular membrane
in an, as yet, undeﬁned manner. Given this interesting set of
results, we have carefully surveyed TCR/pMHC complex crystal-
lographic data searching for structural evidence consistent with
model 2.
SURVEY OF MOLECULAR CONTACTS IN AVAILABLE CRYSTAL
STRUCTURES DOES NOT SUPPORT THE TCR Cα–Cα
DIMERIZATION MODEL
Protein–protein interactions in a living system and in a protein
crystal obey the same physico-chemical rule in seeking an energy
minimum. Not surprisingly, there have been numerous exam-
ples of protein–protein interactions observed in crystal structures
reﬂecting physiologically relevant interactions in cellular systems.
The ﬁeld of structural immunology has served to unravel key
aspects of immune function. Over the last 16 years, complex
structures of TCR/pMHC, co-receptor/pMHC, and the ternary
complex of TCR/pMHC/CD4 derived from crystal structures have
substantively advanced the ﬁeld of immunology and opened new
avenues for cellular and molecular functional studies (reviewed
in Rudolph et al., 2006; Smith-Garvin et al., 2009; Kim et al., 2012;
Kuhns and Davis, 2012;Wang and Reinherz, 2012; Yin et al., 2012).
Occasionally, crystal packing patterns may suggest a misleading
conclusion but that can be assessed through further structural
analyses and vetted by mutational studies directed at crystal-
lographically identiﬁed contact sites to ensure their biological
relevance.
We then assert that if a TCR, in fact, dimerizes through its Cα
domain on the T cell surface, one should observe such a dimer in at
least some TCR/pHMC crystal lattices. Based on this assumption,
we set out to test the proposed TCR dimer model by scrutinizing
available TCR/pMHC crystal structures. Table 1 lists 22 crystal
structures of TCRs in complex with pMHCs. These cover both
peptide-bound class I and class II MHC molecules from humans
and mice including one ternary complex of a TCR/pMHC/CD4
deposited in the protein data bank (PDB). Only those struc-
tures containing a TCR Cα domain were included in this survey.
The molecular packing pattern in the crystal for each of these
structures listed in Table 1 has been generated and displayed via
computer graphics. Speciﬁcally, potential interactions involving
the Cα domain in the crystals were scrutinized. Interestingly, only
three structures manifest Cα–Cα interaction (PDB codes 2PYF,
3FFC, and 3MBE). In the remaining 19 crystal structures, the
TCR Cα domain either contacts the TCR β chain or the MHC
molecule or remains unengaged in molecular interactions with
other molecules.
Figure 2A shows the Cα–Cα interactions in structures 2PYF
and 3MBE. In 2PYF, the manner in which two Cα domains contact





1BD2 I Human Cα contacts TCR Vβ
1FYT II Human Cα contacts MHCII β2
1J8H II Human Cα contacts MHCII β2
1MI5 I Human Cα contacts TCR Vβ
1OGA I Human Cα contacts TCR Vβ
1QSE I Human Cα contacts MHCI β1
1ZGL II Human Fourmolecules.Two Cα contactTCRVβ,
the other MHCII β2
2AK4 I Human Four molecules. Two Cα contact MHCI
α3/β2, the other α3
2CKB I Mouse Cα contacts the elbow of TCR Vβ–Cβ
2IAM II Human Cα contacts MHCII β2
2PYF I Human Cα contacts TCR Cα and Cβ
2WBJ II Human Twomolecules. One Cα contactsMHCII
α2, the other has no contact
3C5Z II Mouse Two molecules. One Cα contacts TCR
Vβ, the other Cβ
3C6O II Mouse Two molecules. One Cα contacts MHC
α2, and the other Vβ–Cβ
3FFC I Human Cα forms dimer. FG loop and G strand
are involved
3HG1 I Human Cα barely contacts Vβ
3MBE II Mouse Cα forms dimer. F and G strands are
involved
3PL6 II Human Cα contacts MHCII β2
3RDT II Mouse Cα contacts MHCII α2
3RGV I Mouse Cα contacts MHCI peptide-binding
domains
3SJV I Human Four molecules. All Cα contact the
MHCI peptide-binding domain
3TOE II Human Cα contacts CD4 only (this is a TCR/
pMHC/CD4 complex)
PDB ﬁle numbers showing any Cα–Cα contacts are highlighted in bold.
one another cannot be regarded as forming a dimer. They barely
touch, doing so in asymmetric fashion. On the other hand, the
two Cα domains in the structure 3MBE do form a dimer, but
that dimer would force the two TCR molecules to lie horizontally
on the plasma membrane in a clearly unphysiologic mode. The
structure 3FFC, depicted in two views in Figure 2B appears to
present the best possible dimer. The side view illustrates two TCR
heterodimers standing side by side with their C-termini pointed
toward the membrane at the bottom. The top view orientation is
looking down from above. In this perspective, it is obvious that
neither F strand nor C strand of the Cα domain is located at
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FIGURE 2 | “Dimers” involving the Cα domain in αβTCR/pMHC
complexes. (A)The dimeric model in two crystal structures. The structure
of 2PYF in the right panel is not a symmetric dimer, whereas the structure
of 3MBE in the left panel reveals a dimer apparently lying ﬂat on the cell
membrane, so of questionable biological signiﬁcance. In panels (A) and
(B) the Cα domains are shown in dark blue and orange. (B)Two views of
the structure of 3FFC show a possible dimer standing on the plasma
membrane. From the top view, it is apparent that neither C strand,
nor F strand participates in dimer formation. (C)The potential N-linked
glycosylation sites in mouse (left panel) and human (right panel) are labeled
with asparagines in blue color. These sites are all at the outer face of the Cα
domain.
the interface. Thus, although the dimer in this one crystal might
mediate a Cα–Cα interaction of potential physiologic signiﬁcance,
it is not in agreement with the proposed TCR dimer model. The
conclusion is very clear from the survey: there is no crystallo-
graphic evidence to support TCR dimerization through the C and
F β strands on the Cα domain’s outer face inferred from earlier
mutational study.
POTENTIAL GLYCANS ON THE Cα DOMAIN PREVENT TCR
DIMERIZATION AT ITS OUTER SURFACE
An additional argument against the proposed TCR dimer model
is the fact that there are potential glycosylation sites located on the
outer face of the TCR Cα domain (Figure 2C). It is known that
almost all immune receptors are glycosylated (Rudd et al., 2001).
In fact, the most common post-translational modiﬁcation of these
cell surface receptors is the N-linked glycosylation on Asn in the
N-X-S/T sequon, where X represents any kind of amino acid in the
motif. The glycan has GlcNAc2Man3 as its core attached to Asn.
Many carbohydrate residues then further branch out from the
two forked mannoses to form a rather long (more than a dozen
residues) oligosaccharide adduct, signiﬁcantly extending away
from the protein surface. Functionally, the glycans help to ori-
ent ligand-binding surfaces, impact lateral mobility of receptors,
protect receptors from the attack by protease and also restrict
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non-functional protein–protein interactions (Rudd et al., 2001).
Published crystal structures of these receptors when expressed in
eukaryotic systems, usually reveal the sugar moieties linked to Asn
residue at those potential glycosylation sites. In our early work of
the mouse class I restricted TCR, N15, the protein was expressed
in the CHO Lec 3.2.8.1 system and subsequently treated with
Endo-H. One sugar moiety left at each of the potential N-linked
glycosylation sites was well deﬁned in the electron density in the
crystal structure (PDB code 1NFD;Wang et al., 1998) demonstrat-
ing that these sites are utilized in the TCR. The two sites at Asn185
and Asn199 on the murine Cα domain are shown in Figure 2C,
the left panel. Depicted on the right panel of Figure 2C is the
human class II restricted TCR (expressed in E. coli), E8 (PDB code
2IAM). Three potential glycosylation sites on its Cα domain are
shown at Asn141, Asn175, and Asn186. The TCR C module is
conserved within a particular species on all TCRs. As shown in the
mouse, the two glycans are at the Ig-like domain’s EF loop (N185
in 1NFD) and the FG loop (N189 in 1NFD). For the human (in
2IAM), the three glycans are positioned at the beginning of C
strand (N141), EF loop (N175), and on the F strand (N186). The
crystal structure, however, did not show any glycans attached to
the sites since the protein was expressed in E. coli. According to
the rules reported from a systematic study (Kasturi et al., 1997),
for a sequon of N-X-S, as long as the X is not Trp, Asp, Glu, or
Leu, the site should be efﬁciently glycosylated. For the human
TCR Cα domain, the three conserved potential sites are N141VS,
N175KS, and N186NS. Hence, glycans are expected to exist on
those sites, all located on the outer face of Cα domain. Most
notable is the conserved site for glycan addition on the F strand
in human TCR Cα domain. In the presence of the glycan adduct,
it is not possible for this β strand to be involved in TCR homod-
imerization. Instead, this and the other Cα domain glycans likely
prevents lateral protein–protein interaction and maintain the TCR
αβ heterodimer upright on the cell surface as reviewed previously
(Rudd et al., 2001).
NEW INSIGHTS ON TCR BIOLOGY
A variety of recent experiments suggest that the TCR is a
mechanosensor, converting mechanical energy into biochemical
signals upon ligation (Kim et al., 2009; Li et al., 2010; Ma and
Finkel, 2010; Husson et al., 2011; Judokusumo et al., 2012). Tan-
gential force applied by optical tweezer technology using speciﬁc
pMHC ligand-coated beads results in the αβ heterodimer exerting
torque on the CD3 heterdimers as a consequence of molecular
movement (Kim et al., 2009). Such force, being low piconewton in
magnitude, is readily generated as T cells scan various epithelial or
APC surfaces during immune surveillance via integrin-mediated
adhesion events and prior to TCR-driven stop movement sig-
nals. At the immunological synapse, when cell migration has
terminated, force continues to be exerted on the TCR via micro-
cluster formation and retrograde actin-based trafﬁcking from
inside the cell (Yokosuka et al., 2008). Predicted alterations in
TCR TM segments and surrounding lipid likely convert ectodo-
main ligation into the earliest intracellular signaling events (Kim
et al., 2012).
CONCLUDING REMARKS
In summary, from our survey of TCR crystal structures, there is no
evidence consistent with the proposed TCR dimer model among
nearly two-dozen TCR/pMHC complex structures studied. More
strikingly, the presence of bulky glycans on the outer face of TCR
Cα domain, including the F strand in the human TCR,will prevent
TCR dimerization there. Observed microcluster formation at the
immunological synapse almost certainly results from interactions
involving other TCR complex elements, including the cytoplas-
mic tail.
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